NFE2L2 and Obesity: Therefore, the pharmacological or phytochemical activation of NRF2 mitigates obesity, insulin resistance, and other comorbidities, including cardiac remodeling and fibrosis, as well as diastolic dysfunction, thus improving cardiac dysfunction.